{"product_id":"memorial-sloan-kettering-cancer-center-the-pathology-of-neoplastic-diseases-2026","title":"Memorial Sloan Kettering Cancer Center The Pathology of Neoplastic Diseases 2026","description":"\u003ch1\u003eMemorial Sloan Kettering Cancer Center The Pathology of Neoplastic Diseases 2026\u003c\/h1\u003e\r\n\u003ch1\u003eThe Pathology of Neoplastic Diseases 2026 – GI, GU \u0026amp; Thoracic Pathology Review\u003c\/h1\u003e\r\n\u003ch2\u003eFull Course Description\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eThe Pathology of Neoplastic Diseases 2026\u003c\/strong\u003e is an advanced educational pathology program focused on selected high-yield areas of neoplastic disease, including \u003cstrong\u003egenitourinary pathology, gastrointestinal pathology, and thoracic pathology\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eDesigned for practicing pathologists, pathology residents, and fellows, this course provides a practical review of modern diagnostic approaches to tumors and tumor-like lesions. The program emphasizes current classifications, difficult differential diagnoses, tumor staging, pathology reporting, immunohistochemistry, molecular testing, and the growing role of therapeutic and predictive biomarkers.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe course includes focused teaching on common diagnostic dilemmas in daily surgical pathology practice, including lung cancer diagnosis in small biopsies and cytology specimens, renal tumors with clear cytoplasm, prostate cancer grading and reporting, urothelial carcinoma risk stratification, pancreatic neoplasms, hepatocellular tumors, neuroendocrine neoplasms, mediastinal tumors, pleural tumors, and inherited renal tumor syndromes.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eA major strength of this program is its integration of morphology with advanced diagnostic techniques. Learners will review the appropriate use of immunohistochemistry, molecular pathology, artificial intelligence applications, predictive biomarkers, and clinicopathologic correlation in modern cancer diagnosis.\u003c\/p\u003e\r\n\r\n\u003ch2\u003eOriginal Course Dates\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eApril 27, 2026 – May 1, 2026\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eAfter completing this course, learners should be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eApply current classifications and diagnostic criteria for tumors and tumor-like lesions.\u003c\/li\u003e\r\n \t\u003cli\u003eSelect appropriate ancillary diagnostic tools, including immunohistochemistry and molecular pathology.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize important differential diagnoses and diagnostic pitfalls in neoplastic pathology.\u003c\/li\u003e\r\n \t\u003cli\u003eInterpret key clinicopathologic features of gastrointestinal, genitourinary, and thoracic tumors.\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the role of predictive and therapeutic biomarkers in cancer pathology.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove reporting approaches for selected neoplastic diseases.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWho Should Study This Course?\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis course is suitable for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAcademic pathologists\u003c\/li\u003e\r\n \t\u003cli\u003ePrivate-practice pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical pathologists\u003c\/li\u003e\r\n \t\u003cli\u003ePathology residents\u003c\/li\u003e\r\n \t\u003cli\u003ePathology fellows\u003c\/li\u003e\r\n \t\u003cli\u003ePhysicians interested in diagnostic oncology and tumor pathology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eMain Topics Included\u003c\/h2\u003e\r\n\u003ch3\u003eGenitourinary Pathology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHistory and future directions of genitourinary pathology\u003c\/li\u003e\r\n \t\u003cli\u003eArtificial intelligence in genitourinary pathology\u003c\/li\u003e\r\n \t\u003cli\u003eAtypical intraductal proliferations of the prostate\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging GU pathology cases\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular testing in genitourinary neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eRenal cell carcinoma with clear cytoplasm: pitfalls and mimickers\u003c\/li\u003e\r\n \t\u003cli\u003eProstate cancer grading and needle core biopsy reporting\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced prostate cancer pathology reporting\u003c\/li\u003e\r\n \t\u003cli\u003ePredictive and prognostic biomarkers in urothelial carcinoma\u003c\/li\u003e\r\n \t\u003cli\u003eHereditary renal cancer syndromes\u003c\/li\u003e\r\n \t\u003cli\u003eRisk stratification in non-muscle-invasive urothelial carcinoma\u003c\/li\u003e\r\n \t\u003cli\u003ePenile cancer: HPV-associated and HPV-independent tumors\u003c\/li\u003e\r\n \t\u003cli\u003eAdult adrenal gland diagnostic pathology updates\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eGastrointestinal and Hepatopancreatobiliary Pathology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAnal tumors and AJCC 9 staging updates\u003c\/li\u003e\r\n \t\u003cli\u003eAppendiceal tumors and mucinous lesions\u003c\/li\u003e\r\n \t\u003cli\u003eGI tumor biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003ePancreatobiliary cystic and intraductal neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eCytology of cystic pancreatic neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eIntrahepatic cholangiocarcinoma diagnostic strategies\u003c\/li\u003e\r\n \t\u003cli\u003eHepatocellular tumors\u003c\/li\u003e\r\n \t\u003cli\u003eMesenchymal tumors of the GI tract\u003c\/li\u003e\r\n \t\u003cli\u003eGI neuroendocrine neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003ePancreatic solid tumors\u003c\/li\u003e\r\n \t\u003cli\u003eUpper GI tract neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eColorectal cancer staging challenges and emerging updates\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eThoracic Pathology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFrozen section diagnosis in lung cancer\u003c\/li\u003e\r\n \t\u003cli\u003eLung cancer diagnosis in small biopsies and cytology\u003c\/li\u003e\r\n \t\u003cli\u003eNon-small cell lung cancer differential diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular pathology of lung cancer\u003c\/li\u003e\r\n \t\u003cli\u003ePredictive biomarkers in non-small cell lung cancer\u003c\/li\u003e\r\n \t\u003cli\u003eWHO classification updates in lung cancer\u003c\/li\u003e\r\n \t\u003cli\u003eMediastinal tumors\u003c\/li\u003e\r\n \t\u003cli\u003ePleural tumors\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroendocrine tumors of the lung\u003c\/li\u003e\r\n \t\u003cli\u003eThoracic pathology pitfalls and differential diagnoses\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual tumors of the lung\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular solutions for thoracic diagnostic challenges\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eAdditional Areas\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNeuroblastoma pathology reporting and clinical implications\u003c\/li\u003e\r\n \t\u003cli\u003eQ\u0026amp;A sessions and case-based discussions\u003c\/li\u003e\r\n \t\u003cli\u003ePractical pathology reporting challenges\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular and biomarker-driven cancer diagnostics\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Valuable\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis pathology review is especially useful for clinicians and trainees who want a structured update on practical tumor diagnosis across GI, GU, and thoracic pathology. It combines morphology, staging, molecular testing, biomarker evaluation, reporting issues, and case-based differentials in one focused program.\u003c\/p\u003e\r\nThe content is relevant to day-to-day diagnostic pathology practice and may help strengthen confidence when approaching difficult tumor classifications, limited biopsy specimens, unusual morphologic findings, and molecularly complex cancers.","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43113247244386,"sku":"MED-AMB09517","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Memorial-Sloan-Kettering-Cancer-Center-The-Pathology-of-Neoplastic-Diseases-2026-1.jpg?v=1783964419","url":"https:\/\/meducourse.com\/products\/memorial-sloan-kettering-cancer-center-the-pathology-of-neoplastic-diseases-2026","provider":"Meducourse","version":"1.0","type":"link"}